J C L Looi1, L Svensson, O Lindberg, B B Zandbelt, P Ostberg, E Orndahl, L-O Wahlund. 1. Academic Unit of Psychological Medicine, Research Centre for the Neurosciences of Ageing, Australian National University Medical School, Canberra Hospital, Canberra, Australia. Jeffrey.looi@anu.edu.au
Abstract
BACKGROUND AND PURPOSE: Frontostriatal (including the putamen) circuit-mediated cognitive dysfunction has been implicated in frontotemporal lobar degeneration (FTLD), but not in Alzheimer disease (AD) or healthy aging. We sought to assess putaminal volume as a measure of the structural basis of relative frontostriatal dysfunction in these groups. MATERIALS AND METHODS: We measured putaminal volume in FTLD subtypes: frontotemporal dementia (FTD, n = 12), semantic dementia (SD, n = 13), and progressive nonfluent aphasia (PNFA, n = 9) in comparison with healthy controls (n = 25) and patients with AD (n = 18). Diagnoses were based on accepted clinical criteria. We conducted manual volume measurement of the putamen blinded to the diagnosis on T1 brain MR imaging by using a standardized protocol. RESULTS: Paired t tests (P < .05) showed that the left putaminal volume was significantly larger than the right in all groups combined. Multivariate analysis of covariance with a Bonferroni correction was used to assess statistical significance among the subject groups (AD, FTD, SD, PNFA, and controls) as independent variables and right/left putaminal volumes as dependent variables (covariates, age and intracranial volume; P < .05). The right putamen in FTD was significantly smaller than in AD and controls; whereas in SD, it was smaller compared with controls with a trend toward being smaller than in AD. There was also a trend toward the putamen in the PNFA being smaller than that in controls and in patients with AD. Across the groups, there was a positive partial correlation between putaminal volume and Mini-Mental State Examination (MMSE). CONCLUSIONS: Right putaminal volume was significantly smaller in FTD, the FTLD subtype with the greatest expected frontostriatal dysfunction; whereas in SD and PNFA, it showed a trend towards being smaller, consistent with expectation, compared to controls and AD; and in SD, compared with AD and controls. Putaminal volume weakly correlated with MMSE.
BACKGROUND AND PURPOSE: Frontostriatal (including the putamen) circuit-mediated cognitive dysfunction has been implicated in frontotemporal lobar degeneration (FTLD), but not in Alzheimer disease (AD) or healthy aging. We sought to assess putaminal volume as a measure of the structural basis of relative frontostriatal dysfunction in these groups. MATERIALS AND METHODS: We measured putaminal volume in FTLD subtypes: frontotemporal dementia (FTD, n = 12), semantic dementia (SD, n = 13), and progressive nonfluent aphasia (PNFA, n = 9) in comparison with healthy controls (n = 25) and patients with AD (n = 18). Diagnoses were based on accepted clinical criteria. We conducted manual volume measurement of the putamen blinded to the diagnosis on T1 brain MR imaging by using a standardized protocol. RESULTS: Paired t tests (P < .05) showed that the left putaminal volume was significantly larger than the right in all groups combined. Multivariate analysis of covariance with a Bonferroni correction was used to assess statistical significance among the subject groups (AD, FTD, SD, PNFA, and controls) as independent variables and right/left putaminal volumes as dependent variables (covariates, age and intracranial volume; P < .05). The right putamen in FTD was significantly smaller than in AD and controls; whereas in SD, it was smaller compared with controls with a trend toward being smaller than in AD. There was also a trend toward the putamen in the PNFA being smaller than that in controls and in patients with AD. Across the groups, there was a positive partial correlation between putaminal volume and Mini-Mental State Examination (MMSE). CONCLUSIONS: Right putaminal volume was significantly smaller in FTD, the FTLD subtype with the greatest expected frontostriatal dysfunction; whereas in SD and PNFA, it showed a trend towards being smaller, consistent with expectation, compared to controls and AD; and in SD, compared with AD and controls. Putaminal volume weakly correlated with MMSE.
Authors: J Eritaia; S J Wood; G W Stuart; N Bridle; P Dudgeon; P Maruff; D Velakoulis; C Pantelis Journal: Magn Reson Med Date: 2000-12 Impact factor: 4.668
Authors: Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; Denise Head; Faith Gunning-Dixon; James D Acker Journal: AJNR Am J Neuroradiol Date: 2003-10 Impact factor: 3.825
Authors: D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson Journal: Neurology Date: 1998-12 Impact factor: 9.910
Authors: Robert Perneczky; Janine Diehl-Schmid; Hans Förstl; Alexander Drzezga; Florian May; Alexander Kurz Journal: Eur J Nucl Med Mol Imaging Date: 2007-10-30 Impact factor: 9.236
Authors: S K Madsen; A J Ho; X Hua; P S Saharan; A W Toga; C R Jack; M W Weiner; P M Thompson Journal: Neurobiol Aging Date: 2010-06-11 Impact factor: 4.673
Authors: Mark Walterfang; Jeffrey Chee Leong Looi; Martin Styner; Ruth H Walker; Adrian Danek; Marc Niethammer; Andrew Evans; Katya Kotschet; Guilherme R Rodrigues; Andrew Hughes; Dennis Velakoulis Journal: Psychiatry Res Date: 2011-03-05 Impact factor: 3.222
Authors: Eric Maltbie; Kshamta Bhatt; Beatriz Paniagua; Rachel G Smith; Michael M Graves; Matthew W Mosconi; Sarah Peterson; Scott White; Joseph Blocher; Mohammed El-Sayed; Heather C Hazlett; Martin A Styner Journal: Neuroimage Date: 2011-08-26 Impact factor: 6.556
Authors: Cathra Halabi; Anasheh Halabi; David L Dean; Pei-Ning Wang; Adam L Boxer; John Q Trojanowski; Stephen J Dearmond; Bruce L Miller; Joel H Kramer; William W Seeley Journal: Alzheimer Dis Assoc Disord Date: 2013 Jan-Mar Impact factor: 2.703
Authors: Jeffrey C L Looi; Priya Rajagopalan; Mark Walterfang; Sarah K Madsen; Paul M Thompson; Matthew D Macfarlane; Chris Ching; Phyllis Chua; Dennis Velakoulis Journal: Aust N Z J Psychiatry Date: 2012-09-18 Impact factor: 5.744
Authors: David Jakabek; Brian D Power; Matthew D Macfarlane; Mark Walterfang; Dennis Velakoulis; Danielle van Westen; Jimmy Lätt; Markus Nilsson; Jeffrey C L Looi; Alexander F Santillo Journal: Hum Brain Mapp Date: 2018-06-20 Impact factor: 5.038
Authors: J Kassubek; E H Pinkhardt; A Dietmaier; A C Ludolph; G B Landwehrmeyer; H-J Huppertz Journal: AJNR Am J Neuroradiol Date: 2011-06-16 Impact factor: 3.825
Authors: Matthew D Macfarlane; Jeffrey C L Looi; Mark Walterfang; Gabriela Spulber; Dennis Velakoulis; Martin Styner; Milita Crisby; Eva Orndahl; Timo Erkinjuntti; Gunhild Waldemar; Ellen Garde; Michael G Hennerici; Hansjörg Bäzner; Christian Blahak; Anders Wallin; Lars-Olof Wahlund Journal: Am J Geriatr Psychiatry Date: 2013-08-01 Impact factor: 4.105